Business Context and Reporting Period
Company: Achieve Life Sciences, Inc. (ACHV)
Filing Type: Form 8-K (Current Report)
Report Date: March 24, 2026
Reporting Period: Fourth quarter and full year ended December 31, 2025
This filing serves as a notification that the company issued a press release on March 24, 2026, announcing its financial results for the specified period. The detailed results are contained in Exhibit 99.1, which is furnished but not deemed "filed" for purposes of Section 18 of the Exchange Act.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. The following metrics are not present in this document:
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Investors must refer to the attached press release (Exhibit 99.1) for these figures.
Material Changes
The filing text does not provide specific numerical comparisons or descriptions of material changes versus the prior comparable period. It only confirms the announcement of results for the fourth quarter and year ended December 31, 2025.
Guidance, Outlook, and Risks
Management Commentary and Guidance: The text does not include specific guidance, outlook, or management commentary. These details are expected to be in the referenced press release (Exhibit 99.1).
Risks and Contingencies: No specific risks or contingencies are detailed in this cover document.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 24, 2026) for actual revenue, net income, and cash flow figures.
- Verify the specific details of the fourth quarter and full-year 2025 performance against prior year guidance.
- Check for any forward-looking statements or updated financial guidance within the press release.
- Confirm the status of the company's liquidity and capital resources as detailed in the full financial report.